Christopher Li MD, PhD

proteomics , pathology , epidemiology , biorepository , hormones , biomarker discovery , prevention (early detection) , environmental factors (exercise, smoking) , risk (susceptibility, exposure) , prognosis , outcome (survival)


Dr. Li's research focuses on breast cancer and understanding factors related to its etiology and outcomes using a multidisciplinary approach. He studies the relationships between various hormonal exposures and risks of different types of breast cancer based on their morphology and expression of different tumor markers, risk factors for second primary breast cancer among breast cancer survivors, identifying markers that could be used for the early detection of different cancers using various proteomic platforms, examining disparities in cancer stage, treatment, and survival by race/ethnicity.


Fred Hutch Public Health Sciences - Translational Research Professor and Program Head
University of Washington School of Public Health Epidemiology Research Full Professor